NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a commercial-stage biopharmaceutical company that develops and markets biosurgical and antibody-based products, announced today that Michael Burshtine, Senior Vice President and Chief Financial Officer, is scheduled to give a company presentation at the Cowen and Company 7th Annual Global Health Care Conference on Wednesday, November 8, 2006 at 2:25 pm London time (9:25 am ET, 6:25 am PT) at The Landmark London Hotel in London, England.
